TMP1 (IMAGE)

The University of Hong Kong

TMP1

Caption

TMP1, the new bispecific inhibitor, has broad-spectrum antiviral efficacy against multiple human-pathogenic coronaviruses, including the highly pathogenic SARS-CoV-2, SARS-CoV-1 and MERS-CoV.

Credit

The University of Hong Kong

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.